Clinical Trials

Oncology Research - Clinical Trials

The J. Phillip Citta Cancer Center provides patients access to national and regional clinical research studies. The availability of these studies in the treatment of cancer, chemoprevention, and supportive care allow patients the option to participate in the latest treatment options including investigational drugs.

For more information, please call

Jonathan A. Gapilango RN MSN OCN
Director, Oncology Research & Oncology Data Ctr
J. Phillip Citta Regional Cancer Center
Community Medical Center

(732) 557-8239 office
(732) 557-8599 fax

Open Protocol List as of September 23, 2016

Breast Clinical Trials

A011104 / 6694

Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer


A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation

Lung Clinical Trials

Low Dose CT Scan Lung Cancer Screening Protocol

The purpose of this study is to evaluate using “low-dose CT scans” as a screening mechanism for lung cancer

RTOG 1306

A Randomized Phase II study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)


Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)


A Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)


A Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for patients with tumors harboring the ALK fusion protein

NRG- LU001

Randomized PHASE II Trial of Concurrent Chemoradiotherapy +/- METFORMIN HCL In Locally Advanced NSCLC

Colon Clinical Trial

NSABP Protocol C-13

A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib following completion of standard Chemotherapy for Patients with Stage III colon cancer (ARGO)

Cyberknife Clinical Trials

RSSSearch Patient Registry Protocol

An international, multi-center ongoing database designed to standardize the collection of data on the use of stereotactic surgery (SRS)/ stereotactic body radiation therapy (SBRT) systems in everyday practice

UPMC #09-031

Prospective Evaluation of Hypofractionated Stereotactic Body Radiotherapy for Low and Intermediate Risk Prostate Cancer

NJCK 12-01

Prospective Evaluation of Hypofractionated Stereotactic Body Radiotherapy for High Risk Prostate Cancer

UPCI 10-027

Phase II Study For Curative Intent Treatment got Patients with Oligometastatic disease at Initial Presentation

UPCI # 10-028

“Phase II Study of Stereotactic Radiosurgery / Stereotactic Body Radiation Therapy for Patients with Oligo-Recurrent Disease

[ top ]